Clinical Trials Logo

Abdominal Pain clinical trials

View clinical trials related to Abdominal Pain.

Filter by:

NCT ID: NCT02620501 Recruiting - Dysphagia Clinical Trials

Does Use of Topical Lidocaine in EGD Reduce Amount of IV Midazolam and Fentanyl Required and Shorten Recovery Time

Start date: July 2015
Phase: N/A
Study type: Interventional

Patients will be randomized to a placebo or study group who will receive topical lidocaine prior to EGD. Amount of medication used, recovery time, patient/endoscopist satisfaction will then be assessed.

NCT ID: NCT02613078 Recruiting - Clinical trials for Irritable Bowel Syndrome

Hypnotherapy vs. Probiotics in Children With IBS and Functional Abdominal Pain

Start date: March 2016
Phase: N/A
Study type: Interventional

Current study aims to investigate the influence of gut-directed hypnotherapy and probiotic nutritional supplement (SymbioLact B) on gastrointestinal symptoms in children with functional abdominal pain or irritable bowel syndrome compared to self-observation only. The study also includes collection of psychometric data (emotional and behavioral problems, pain coping strategies), data on activity of the autonomous nerve system as measured by heart rate variability and data on stress response (saliva cortisol levels).

NCT ID: NCT02594774 Recruiting - Abdominal Pain Clinical Trials

Efficacy of Osteopathic Treatment in Function Abdominal Pain in Children and Adolescents

Start date: October 2015
Phase: N/A
Study type: Interventional

The objective is to evaluate the efficacy of osteopathic treatment as an adjunct to standard medical treatment in reducing child functional abdominal pain. A convenience sample that includes no more than 30 patients per study group (n = 60) are being recruited. As an exploratory study the investigators did not proceed to make any sample size calculation. This is a comparative study of two quasi-experimental interventions (standard treatment vs. standard treatment + Osteopathy). This will be a single-blind trial where only the evaluator will be blinded. The principal outcome will be pain measured by a visual analog scale. A version with more appropriate pictograms for pediatric patients is used. Measurements will be taken at baseline (baseline measurements) at 4, 8 weeks (the duration of interventions) and 6 months post-study.

NCT ID: NCT02536144 Recruiting - Diarrhea Clinical Trials

The Clinical Application of MCCES in Examination of Human Colon

Start date: August 2015
Phase: N/A
Study type: Interventional

This study is to determine the feasibility and safety of magnetic-controlled capsule endoscopy system in examination of human colon under the real time monitoring by colonoscopy in the clinical application.

NCT ID: NCT02105090 Recruiting - Abdominal Pain Clinical Trials

Efficacy Study of Articaine Lozenge to Enhance the Procedural Compliance of the Adults Undergoing Gastroduodenoscopy

Start date: October 2014
Phase: Phase 4
Study type: Interventional

The purpose of this study is to examine in prospective, double-blinded randomised manner the ability of novel articaine-containing lozenge to enhance the procedure related compliance (compared to placebo) of the adult patients undergoing upper gastrointestinal endoscopy.

NCT ID: NCT02064127 Recruiting - Abdominal Pain Clinical Trials

Triage of Abdominal Pain in the Emergency Department

Start date: March 2014
Phase: N/A
Study type: Observational

The investigators aim to evaluate in a retrospective study the performance of the Swiss Emergency Triage Scale to identify at the door of the Emergency Department patients requiring emergent intervention.

NCT ID: NCT01675050 Recruiting - Clinical trials for Functional Abdominal Pain

A Placebo-controlled Crossover Trial Using Cyproheptadine To Treat Children With Functional Abdominal Pain

Start date: August 2012
Phase: Phase 2
Study type: Interventional

The investigators hypothesize that using Cyproheptadine in a placebo-controlled crossover trial would help relieve abdominal pain associated with FAP in children, achieving a greater response than that observed with placebo. In addition to assessing self-report of pain and other symptoms, the investigators also propose to perform experimental somatic pain testing to determine if there is evidence of peripherally-maintained central sensitization in children with FAP. The investigators also hypothesize that there will be an increase in somatic pain threshold after completion of a Cyproheptadine course compared to baseline testing prior to treatment, and compared to placebo. This would allow children with FAP to return to normal function, improve symptoms and overall general well-being

NCT ID: NCT01610193 Recruiting - Abdominal Pain Clinical Trials

The Value of Pancreatic Stone Protein in Predicting Acute Appendicitis

Start date: June 2012
Phase: N/A
Study type: Observational

PSP (Pancreatic Stone Protein) is a compound naturally produced mainly in the pancreas and the gut. There is evidence from experimental and clinical trials that the levels of PSP in the blood rise in the presence of inflammation or infection. What is not yet well known about PSP is whether it is superior to other established blood tests (e.g. WBC or CRP) in predicting appendicitis in patients that present at the emergency room with abdominal pain and a clinical suspicion of appendicitis.

NCT ID: NCT01587846 Recruiting - Abdominal Pain Clinical Trials

Lactobacillus Reuteri in Treatment of Functional Abdominal Pain and Chronic Constipation in Children

Start date: October 2012
Phase: Phase 3
Study type: Interventional

Beneficial therapeutic effect of probiotics has been reported in children with irritable bowel syndrome, but not consistently in other functional gastrointestinal disorders. Although there is evidence that probiotics increase stool frequency and decrease stool consistency in healthy individuals the evidence for efficacy in constipation is limited. Children with functional abdominal pain (FAP) and constipation will be included in the study. Children with FAP will be randomized in one of two groups and will receive either L. reuteri in a daily dose of 108 CFU, or placebo during three months. Children with chronic constipation will receive either L. reuteri in a daily dose of 108 CFU and lactulose, or placebo and lactulose. Frequency and intensity of episodes of abdominal pain during and after intervention will be recorded in children with FAP. Frequency of defecation, stool consistency and need for lactulose will be recorded in children with chronic constipation.

NCT ID: NCT01255345 Recruiting - Clinical trials for Irritable Bowel Syndrome

Female Chronic Pelvic Pain

Female CPP
Start date: January 2011
Phase: N/A
Study type: Observational

The purpose of this study is to investigate the frequency and severity of chronic pelvic pain (CPP) in adult women living in Copenhagen Country and Zealand Country (total population 2,4 million), Denmark, in relation to selected factors, such as basic demographic and clinical factors, health related quality of life, physical activity and abnormal muscular findings in the pelvic area.